Clinical Trials Logo

Filter by:
NCT ID: NCT02311296 Withdrawn - Pneumonia Clinical Trials

Reduced Ventilator-Free Days and Bacterial Colonization of Sub-Glottic Secretions

Start date: November 2, 2020
Phase:
Study type: Observational

Ventilator associated pneumonia (VAP) is common problem among ICU patients and major source of infection among patients receiving mechanical ventilation. Patients on mechanical ventilation accumulate secretion leading to aspiration of infected secretions. Using new generation endotracheal tube (Hi-Lo tube) can reduce the incidence of VAP.

NCT ID: NCT02309632 Withdrawn - Clinical trials for Pancreatic Neoplasms

Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

Start date: November 2015
Phase: N/A
Study type: Interventional

100 subjects who have a family history of pancreatic cancer (PC), or known genetic syndromes associated with increased risk of pancreatic cancer, will be followed for five years. This data will be used to determine the pancreatic cancer and precancerous lesion detection rate in High Risk Individuals (HRIs). Subjects may agree to annual imaging and annual biomarkers or to biomarkers only.

NCT ID: NCT02309268 Withdrawn - Atrial Fibrillation Clinical Trials

Atrial Appendage Closure Prospective Observational Study

LARIAT
Start date: June 2012
Phase: N/A
Study type: Observational

The purpose of this research is to monitor how well patients do after surgery for treatment of left atrial appendage (LAA).

NCT ID: NCT02308800 Withdrawn - Clinical trials for Foot Ulcer, Diabetic

Negative Pressure Wound Therapy as a Drug Delivery System (ADANPWT)

ADA NPWT
Start date: January 2015
Phase: N/A
Study type: Interventional

The investigators plan a randomized clinical trial of 150 patients with infected diabetes-related lower extremity wounds to compare the clinical and economic effectiveness of negative pressure wound therapy with continuous irrigation and negative pressure wound therapy without irrigation. The investigators will enroll 150 patients from two centers: The University of Texas Southwestern University Hospital and Parkland Hospital. The investigators will screen and enroll patients with wounds in the inpatient setting. Patients will randomized to receive traditional NPWT or NPWT with continuous irrigation while they are hospitalized. The average hospitalization for patents that receive NPWT is 13.3 days. Patients that do not have their wound surgically closed during hospitalization will be discharged with negative pressure wound therapy without irrigation for up to a total of four weeks of therapy. After discharge from the hospital, subjects will be seen twice weekly by home health, and the investigators will evaluate subjects in clinic every 7 days (±7 days) for a total of 16-week period or until the wound heals.

NCT ID: NCT02308358 Withdrawn - Clinical trials for Outcomes of Allograft

Long Term Outcomes of Osteochondral Allografts for Osteochondral Defects of the Knee

LongTermOC
Start date: May 2014
Phase:
Study type: Observational

The purpose of this study is to evaluate the functional and clinical outcomes of patients receiving femoral condyle osteochondral allografts, to evaluate potential predisposing factors to failure of such grafts, and to compare the overall outcomes of the grafts to the current standard of care for smaller lesions, microfracture. Our hypothesis is that patients treated with these allografts will demonstrate significant functional improvement as measured by validated outcome scoring measures and their function will be at least equal to that of microfracture outcomes.

NCT ID: NCT02307474 Withdrawn - Clinical trials for Renal Cell Carcinoma

A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer

Start date: September 2015
Phase: N/A
Study type: Interventional

This pilot clinical trial studies the side effects of stereotactic body radiation therapy and pazopanib hydrochloride in treating patients with kidney cancer who are not able to undergo surgery. Stereotactic body radiation therapy is a specialized radiation therapy that delivers high doses of radiation directly to the tumor and may kill more tumor cells and cause less damage to normal tissue. Pazopanib hydrochloride may stop the growth of tumor cells by blocking an enzyme needed for cell growth. Giving pazopanib hydrochloride before stereotactic body radiation therapy may help make the tumor smaller and be an alternative treatment for patients who cannot undergo surgery.

NCT ID: NCT02306512 Withdrawn - Lentigo Maligna Clinical Trials

Mohs and Immunofluorescence for Malignant Melanoma In Situ

Start date: June 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if immunofluorescence (IF) can effectively identify features of malignant melanoma in situ, on sun-damaged skin, in the setting of Mohs Micrographic Surgery.

NCT ID: NCT02303964 Withdrawn - Shock, Hemorrhagic Clinical Trials

Pre-Hospital Use of Plasma for Traumatic Hemorrhage

PUPTH
Start date: November 2014
Phase: Phase 2/Phase 3
Study type: Interventional

Type A Thawed Plasma (TP) will be compared in polytrauma patients who receive only Normal Saline (NS) (standard of care) before arrival at the hospital. The purpose of this study is to determine if prehospital administration of thawed plasma can reduce mortality of patients who have lost a large amount of blood due to their injuries, compared to those receiving standard of care.

NCT ID: NCT02302755 Withdrawn - Clinical trials for Dense Deposit Disease

TP10 Use in Patients With C3 Glomerulopathy (C3G)

Start date: November 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety of repeated TP10 dosing in pediatric and adult patients with C3G and to evaluate the activity of TP10 in pediatric and adult patients with C3G, as measured by the proportion of patients with normalization of serum C3, serum C3 breakdown products, or alternative pathway (AP) complement activity.

NCT ID: NCT02301845 Withdrawn - Clinical trials for Pneumonia, Aspiration

Validation of Aspiration Markers

Start date: February 2016
Phase: Phase 1
Study type: Interventional

This is an interventional crossover study aimed at validating diatom shells as a marker for cuff leak and microaspiration in mechanically ventilated, critically ill patients.